COMPLEMENT C3 ANTIGEN BINDING PROTEINS
Antigen-binding proteins with specificity to complement C3 and C3b are provided.Methods of treating complement C3-mediated diseases and disorders, methods of inhibiting the activity of the complement Classical pathway (CP), Lectin pathway (LP), and/or Alternative pathway (AP), and methods of inhibit...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | LEISNER, Christian BORRAS, Leonardo SCHEIFELE, Fabian ESCHER, Dominik JUNGMICHEL, Stephanie RICHLE, Philipp Robert |
| description | Antigen-binding proteins with specificity to complement C3 and C3b are provided.Methods of treating complement C3-mediated diseases and disorders, methods of inhibiting the activity of the complement Classical pathway (CP), Lectin pathway (LP), and/or Alternative pathway (AP), and methods of inhibiting the activity of choroidal-localized complement C3 are also provided.
L'invention concerne des protéines de liaison à l'antigène ayant une spécificité pour le complément C3 et C3b. L'invention concerne également des méthodes de traitement de maladies et de troubles à médiation par C3 du complément, des procédés d'inhibition de l'activité de la voie classique (CP), de la voie lectine (LP), et/ou de la voie alternative (AP) du complément, et des procédés d'inhibition de l'activité du complément C3 localisé sur la choroïde. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2022171771A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2022171771A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2022171771A13</originalsourceid><addsrcrecordid>eNrjZFBz9vcN8HH1dfULUXA2VnD0C_F0d_VTcPL0c_H0c1cICPIPcfX0C-ZhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGRkaG5obm5oaOhsbEqQIAQigkWA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMPLEMENT C3 ANTIGEN BINDING PROTEINS</title><source>esp@cenet</source><creator>LEISNER, Christian ; BORRAS, Leonardo ; SCHEIFELE, Fabian ; ESCHER, Dominik ; JUNGMICHEL, Stephanie ; RICHLE, Philipp Robert</creator><creatorcontrib>LEISNER, Christian ; BORRAS, Leonardo ; SCHEIFELE, Fabian ; ESCHER, Dominik ; JUNGMICHEL, Stephanie ; RICHLE, Philipp Robert</creatorcontrib><description>Antigen-binding proteins with specificity to complement C3 and C3b are provided.Methods of treating complement C3-mediated diseases and disorders, methods of inhibiting the activity of the complement Classical pathway (CP), Lectin pathway (LP), and/or Alternative pathway (AP), and methods of inhibiting the activity of choroidal-localized complement C3 are also provided.
L'invention concerne des protéines de liaison à l'antigène ayant une spécificité pour le complément C3 et C3b. L'invention concerne également des méthodes de traitement de maladies et de troubles à médiation par C3 du complément, des procédés d'inhibition de l'activité de la voie classique (CP), de la voie lectine (LP), et/ou de la voie alternative (AP) du complément, et des procédés d'inhibition de l'activité du complément C3 localisé sur la choroïde.</description><language>eng ; fre</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220818&DB=EPODOC&CC=WO&NR=2022171771A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,782,887,25571,76555</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220818&DB=EPODOC&CC=WO&NR=2022171771A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LEISNER, Christian</creatorcontrib><creatorcontrib>BORRAS, Leonardo</creatorcontrib><creatorcontrib>SCHEIFELE, Fabian</creatorcontrib><creatorcontrib>ESCHER, Dominik</creatorcontrib><creatorcontrib>JUNGMICHEL, Stephanie</creatorcontrib><creatorcontrib>RICHLE, Philipp Robert</creatorcontrib><title>COMPLEMENT C3 ANTIGEN BINDING PROTEINS</title><description>Antigen-binding proteins with specificity to complement C3 and C3b are provided.Methods of treating complement C3-mediated diseases and disorders, methods of inhibiting the activity of the complement Classical pathway (CP), Lectin pathway (LP), and/or Alternative pathway (AP), and methods of inhibiting the activity of choroidal-localized complement C3 are also provided.
L'invention concerne des protéines de liaison à l'antigène ayant une spécificité pour le complément C3 et C3b. L'invention concerne également des méthodes de traitement de maladies et de troubles à médiation par C3 du complément, des procédés d'inhibition de l'activité de la voie classique (CP), de la voie lectine (LP), et/ou de la voie alternative (AP) du complément, et des procédés d'inhibition de l'activité du complément C3 localisé sur la choroïde.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFBz9vcN8HH1dfULUXA2VnD0C_F0d_VTcPL0c_H0c1cICPIPcfX0C-ZhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGRkaG5obm5oaOhsbEqQIAQigkWA</recordid><startdate>20220818</startdate><enddate>20220818</enddate><creator>LEISNER, Christian</creator><creator>BORRAS, Leonardo</creator><creator>SCHEIFELE, Fabian</creator><creator>ESCHER, Dominik</creator><creator>JUNGMICHEL, Stephanie</creator><creator>RICHLE, Philipp Robert</creator><scope>EVB</scope></search><sort><creationdate>20220818</creationdate><title>COMPLEMENT C3 ANTIGEN BINDING PROTEINS</title><author>LEISNER, Christian ; BORRAS, Leonardo ; SCHEIFELE, Fabian ; ESCHER, Dominik ; JUNGMICHEL, Stephanie ; RICHLE, Philipp Robert</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2022171771A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>LEISNER, Christian</creatorcontrib><creatorcontrib>BORRAS, Leonardo</creatorcontrib><creatorcontrib>SCHEIFELE, Fabian</creatorcontrib><creatorcontrib>ESCHER, Dominik</creatorcontrib><creatorcontrib>JUNGMICHEL, Stephanie</creatorcontrib><creatorcontrib>RICHLE, Philipp Robert</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LEISNER, Christian</au><au>BORRAS, Leonardo</au><au>SCHEIFELE, Fabian</au><au>ESCHER, Dominik</au><au>JUNGMICHEL, Stephanie</au><au>RICHLE, Philipp Robert</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMPLEMENT C3 ANTIGEN BINDING PROTEINS</title><date>2022-08-18</date><risdate>2022</risdate><abstract>Antigen-binding proteins with specificity to complement C3 and C3b are provided.Methods of treating complement C3-mediated diseases and disorders, methods of inhibiting the activity of the complement Classical pathway (CP), Lectin pathway (LP), and/or Alternative pathway (AP), and methods of inhibiting the activity of choroidal-localized complement C3 are also provided.
L'invention concerne des protéines de liaison à l'antigène ayant une spécificité pour le complément C3 et C3b. L'invention concerne également des méthodes de traitement de maladies et de troubles à médiation par C3 du complément, des procédés d'inhibition de l'activité de la voie classique (CP), de la voie lectine (LP), et/ou de la voie alternative (AP) du complément, et des procédés d'inhibition de l'activité du complément C3 localisé sur la choroïde.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2022171771A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | COMPLEMENT C3 ANTIGEN BINDING PROTEINS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T07%3A26%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LEISNER,%20Christian&rft.date=2022-08-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2022171771A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |